Page 17 - Read Online
P. 17

[63]
         whereas light microscopy sections at 6 months post-injection   with the aim of inducing l fibroplasia and volumization.
         showed tight  aggregates  of microspherules surrounded   Moreover, it is characterized as a clear, colorless  fluid
         by  thick  collagen  and histiocytes.  Multinucleated giant   with general physiological inertness and  resistance to
                                                                                                      [63]
         cells surrounding each microspherule were also observed.   decomposition under extreme temperatures.  If the
         All treated  subjects  reported high  satisfaction  levels  at  6   product is inadvertently injected into the blood stream, it
         months, and there were no reports of adverse reactions.  behaves very much like injections of air; small doses of the
                                                             material are distributed throughout the body, while large
         Another pivotal study testing the efficacy of Radiesse® for   doses can cause various severe complications  including
         the treatment of nasolabial folds involved 117 subjects with   emboli and cellulitis.  This product is  overall very
                                                                                 [63]
         a random split-face design. Radiesse® was injected on one   advantageous in the correction of facial defects, and other
         side and collagen was injected on the other.  Radiesse®   intradermal treatments  that previously required excessive
                                               [61]
         was found to be superior to collagen in 79%  of the folds   surgical intervention. [63]
         after 6 months, and required almost half of the volume that
         was used with collagen.  The long-term safety and efficacy   Injectable silicone oils for augmentation of the facial tissues
                            [61]
         of Radiesse® was also tested in the treatment of nasolabial   were  approved by  the  FDA  in  the  early  1960s.   In  spite
                                                                                                     [64]
         folds  by extending the previous study and offering re-  of the  tremendous criticism  that  silicone  has  received
         treatment between 6 and 12 months.  Out of a total of   due to its adverse complications, it has been shown to be
                                         [60]
         117 subjects, 102 patients enrolled and were evaluated at   very effective in facial augmentation.  A clinical study
                                                                                              [64]
         39 months after the last injection.  At 30 months following   conducted by Hevia  demonstrated the efficacy of silicone
                                                                              [65]
                                     [60]
         the last treatment with Radiesse®, improvement was still   oil in soft tissue augmentation. In total 916 patients were
         observed in 40% of the folds, and no adverse events were   treated with  PDMS-1000 (purified polydimethylsiloxane),
         reported.   Safety  and efficacy  has  also been  tested  for   an FDA approved silicone oil, over a six year period during
                 [60]
         an injectable  implant in which where researchers at two   which only 1% showed adverse granulomatous reactions.
                                                                                                             [65]
         different treatment centers injected CaHA into 113 subjects. [5]   All treatments were performed with a serial puncture
         75 patients received single injections and 38 had multiple   technique, which is well-suited for the injection of silicone
         sessions, with most patients receiving 1 mL per session.    oil.  Narins and Beer  note that the oil must be injected
                                                         [5]
                                                                                [64]
                                                                [65]
         The results suggested a very favorable safety profile with a   into the immediate subdermal plane or deeper to avoid
         very high patient satisfaction rating (over 90% indicated that   dermal erythema and ridging.  The volume  should be
         their results were “good” or “very good”) and only 7 minor   limited to no more than 0.5 mL for small areas including the
         adverse events which resolved within one month. [5]  nasolabial fold, and 2.0 mL for larger areas as seen in facial
                                                             lipoatrophy. [64]
         Although the majority of studies did not show any adverse
         effects,  side  effects of Radiesse®  may  include edema,   Another study by Jones et al.  evaluated the injection of
                                                                                      [66]
         erythema  and transient  lumpiness.   Radiesse®  is  not   liquid silicone into HIV patients with facial lipoatrophy. In
                                        [63]
         recommended for lip injection  because of the frequent   this study, 77 patients received either Silikon® 1000 (Alcon
         occurrence of mucosal nodules. [58]   Radiesse® may not   Inc., Fort Worth, TX, USA) or VitreSil® 1000 (Richard James
         be suitable for the treatments of periorbital and glabellar   Inc., Peabody, MA, USA). Less than 2 mL of silicone oil was
         rhytids  secondary  to safety  concerns regarding  embolism   repeatedly injected  at intervals of at least a month  until
         and necrosis. A case was reported in which a 35-year-old   a  state  of “prelipoatrophy”  was  achieved.  Most  patients
         women experienced nausea, vomiting,  headache, ptosis   developed erythema and edema following injection which
         and periorbital pain ten minutes following CaHA injection   resolved within 3 days. Patient satisfaction in this study
         into the nasal tip and dorsum. The symptoms worsened and   was reported to be high although specific details were not
         resulted in sudden monocular vision loss.  Although many   provided.
                                           [62]
         of the fillers discussed may be associated with very mild
         temporary reactions, the injector must remain alert to the   Although many studies have shown the efficacy of silicone
         risk of more serious adverse reactions.             oil, an equal number of studies have highlighted adverse
                                                             reactions secondary to misuse.  The improper use of silicone
                                                                                      [9]
         Permanent fillers                                   oils including incorrect dosage,  improper technique,  and
         Silicone                                            impurity of materials has resulted in serious repercussions
         A primary consideration in the choice of filler is the degree   including cellulitis, product migration, and death.  A report
                                                                                                      [9]
         of maintenance that is required. Some advantages associated   by Requena  et al.  presents  4 cases  in  which patients
                                                                             [67]
         with permanent fillers include low maintenance as a regular   experienced  moderate  to  severe  complications following
         schedule for re-treatmentis not required, and a lower overall   silicone injections.
         cost because the procedure is performed only once.
                                                             All 4 patients were diagnosed with orofacial granulomatosis
                                                                                         [56]
         Liquid injectable silicone, commonly available as Silikon   after 8-12 months  of treatment.  It  was suggested  that
         1000 and AdatoSil 5000, is classified as a permanent filler   the histological appearance of the odemas be  studied as
         for soft tissue augmentation. The chemical composition of   they give direct information regarding the form and purity
         the material is predominantly dimethyl polysiloxane, which   of silicone used, including solid elastomer silicone and oil/
         is  available as fluid with  variable levels of viscosity.  It  is   gel silicone.  The proper use of liquid silicone, i.e. small
                                                                       [56]
         injected into either the deep dermis or subcutaneous fat   volumes,  high  purity,  and the  microdroplet technique,  is
         80                                                                         Plast Aesthet Res || Vol 3 || Mar 23, 2016
   12   13   14   15   16   17   18   19   20   21   22